nodes	percent_of_prediction	percent_of_DWPC	metapath
Desonide—Leukoderma—Thiotepa—sarcoma	0.0526	0.0526	CcSEcCtD
Desonide—Induration—Etoposide—sarcoma	0.0359	0.0359	CcSEcCtD
Desonide—Folliculitis—Dactinomycin—sarcoma	0.0353	0.0353	CcSEcCtD
Desonide—Secondary infection—Epirubicin—sarcoma	0.0306	0.0306	CcSEcCtD
Desonide—Secondary infection—Doxorubicin—sarcoma	0.0283	0.0283	CcSEcCtD
Desonide—Dermatitis contact—Thiotepa—sarcoma	0.0221	0.0221	CcSEcCtD
Desonide—Viral infection—Mitoxantrone—sarcoma	0.0214	0.0214	CcSEcCtD
Desonide—Skin exfoliation—Thiotepa—sarcoma	0.0213	0.0213	CcSEcCtD
Desonide—Leukoderma—Epirubicin—sarcoma	0.0212	0.0212	CcSEcCtD
Desonide—Leukoderma—Doxorubicin—sarcoma	0.0196	0.0196	CcSEcCtD
Desonide—Skin exfoliation—Etoposide—sarcoma	0.0153	0.0153	CcSEcCtD
Desonide—Folliculitis—Epirubicin—sarcoma	0.0143	0.0143	CcSEcCtD
Desonide—Folliculitis—Doxorubicin—sarcoma	0.0132	0.0132	CcSEcCtD
Desonide—Hyperglycaemia—Thiotepa—sarcoma	0.0126	0.0126	CcSEcCtD
Desonide—Infestation NOS—Thiotepa—sarcoma	0.0125	0.0125	CcSEcCtD
Desonide—Infestation—Thiotepa—sarcoma	0.0125	0.0125	CcSEcCtD
Desonide—Rash pustular—Epirubicin—sarcoma	0.0113	0.0113	CcSEcCtD
Desonide—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.0113	0.0113	CcSEcCtD
Desonide—Stinging—Epirubicin—sarcoma	0.0111	0.0111	CcSEcCtD
Desonide—Pharyngitis—Dactinomycin—sarcoma	0.0111	0.0111	CcSEcCtD
Desonide—Hyperglycaemia—Mitoxantrone—sarcoma	0.0109	0.0109	CcSEcCtD
Desonide—Sweating—Vincristine—sarcoma	0.0106	0.0106	CcSEcCtD
Desonide—Rash pustular—Doxorubicin—sarcoma	0.0104	0.0104	CcSEcCtD
Desonide—Sweating—Mitoxantrone—sarcoma	0.0103	0.0103	CcSEcCtD
Desonide—Stinging—Doxorubicin—sarcoma	0.0103	0.0103	CcSEcCtD
Desonide—Mediastinal disorder—Thiotepa—sarcoma	0.0101	0.0101	CcSEcCtD
Desonide—Viral infection—Epirubicin—sarcoma	0.00996	0.00996	CcSEcCtD
Desonide—Mental disorder—Thiotepa—sarcoma	0.00983	0.00983	CcSEcCtD
Desonide—Erythema—Thiotepa—sarcoma	0.00977	0.00977	CcSEcCtD
Desonide—Erythema—Dactinomycin—sarcoma	0.00969	0.00969	CcSEcCtD
Desonide—Pharyngitis—Mitoxantrone—sarcoma	0.00962	0.00962	CcSEcCtD
Desonide—Viral infection—Doxorubicin—sarcoma	0.00922	0.00922	CcSEcCtD
Desonide—Infestation NOS—Etoposide—sarcoma	0.00898	0.00898	CcSEcCtD
Desonide—Infestation—Etoposide—sarcoma	0.00898	0.00898	CcSEcCtD
Desonide—Mediastinal disorder—Vincristine—sarcoma	0.00897	0.00897	CcSEcCtD
Desonide—Dermatitis contact—Epirubicin—sarcoma	0.00889	0.00889	CcSEcCtD
Desonide—Mental disorder—Vincristine—sarcoma	0.00872	0.00872	CcSEcCtD
Desonide—Skin exfoliation—Epirubicin—sarcoma	0.00859	0.00859	CcSEcCtD
Desonide—Cough—Thiotepa—sarcoma	0.00852	0.00852	CcSEcCtD
Desonide—Erythema—Mitoxantrone—sarcoma	0.00844	0.00844	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00826	0.00826	CcSEcCtD
Desonide—Dermatitis contact—Doxorubicin—sarcoma	0.00823	0.00823	CcSEcCtD
Desonide—Skin exfoliation—Doxorubicin—sarcoma	0.00795	0.00795	CcSEcCtD
Desonide—Infection—Thiotepa—sarcoma	0.00792	0.00792	CcSEcCtD
Desonide—Infection—Dactinomycin—sarcoma	0.00786	0.00786	CcSEcCtD
Desonide—Nervous system disorder—Thiotepa—sarcoma	0.00782	0.00782	CcSEcCtD
Desonide—Skin disorder—Thiotepa—sarcoma	0.00774	0.00774	CcSEcCtD
Desonide—Cough—Mitoxantrone—sarcoma	0.00736	0.00736	CcSEcCtD
Desonide—Mediastinal disorder—Etoposide—sarcoma	0.00726	0.00726	CcSEcCtD
Desonide—Infection—Vincristine—sarcoma	0.00702	0.00702	CcSEcCtD
Desonide—Nervous system disorder—Vincristine—sarcoma	0.00693	0.00693	CcSEcCtD
Desonide—Infection—Mitoxantrone—sarcoma	0.00684	0.00684	CcSEcCtD
Desonide—Hyperhidrosis—Vincristine—sarcoma	0.00683	0.00683	CcSEcCtD
Desonide—Pain—Thiotepa—sarcoma	0.00682	0.00682	CcSEcCtD
Desonide—Pain—Dactinomycin—sarcoma	0.00677	0.00677	CcSEcCtD
Desonide—Skin disorder—Mitoxantrone—sarcoma	0.00669	0.00669	CcSEcCtD
Desonide—Hyperhidrosis—Mitoxantrone—sarcoma	0.00666	0.00666	CcSEcCtD
Desonide—Cough—Etoposide—sarcoma	0.00612	0.00612	CcSEcCtD
Desonide—Pain—Vincristine—sarcoma	0.00605	0.00605	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00593	0.00593	CcSEcCtD
Desonide—Pain—Mitoxantrone—sarcoma	0.00589	0.00589	CcSEcCtD
Desonide—Infection—Etoposide—sarcoma	0.00569	0.00569	CcSEcCtD
Desonide—Asthma—Epirubicin—sarcoma	0.00564	0.00564	CcSEcCtD
Desonide—Pruritus—Thiotepa—sarcoma	0.00564	0.00564	CcSEcCtD
Desonide—Skin disorder—Etoposide—sarcoma	0.00556	0.00556	CcSEcCtD
Desonide—Hyperhidrosis—Etoposide—sarcoma	0.00554	0.00554	CcSEcCtD
Desonide—Upper respiratory tract infection—Epirubicin—sarcoma	0.00525	0.00525	CcSEcCtD
Desonide—Asthma—Doxorubicin—sarcoma	0.00522	0.00522	CcSEcCtD
Desonide—Hyperglycaemia—Epirubicin—sarcoma	0.00509	0.00509	CcSEcCtD
Desonide—Infestation NOS—Epirubicin—sarcoma	0.00503	0.00503	CcSEcCtD
Desonide—Infestation—Epirubicin—sarcoma	0.00503	0.00503	CcSEcCtD
Desonide—Rash—Thiotepa—sarcoma	0.00503	0.00503	CcSEcCtD
Desonide—Dermatitis—Thiotepa—sarcoma	0.00502	0.00502	CcSEcCtD
Desonide—Headache—Thiotepa—sarcoma	0.00499	0.00499	CcSEcCtD
Desonide—Rash—Dactinomycin—sarcoma	0.00499	0.00499	CcSEcCtD
Desonide—Pain—Etoposide—sarcoma	0.0049	0.0049	CcSEcCtD
Desonide—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00485	0.00485	CcSEcCtD
Desonide—Sweating—Epirubicin—sarcoma	0.00483	0.00483	CcSEcCtD
Desonide—Hyperglycaemia—Doxorubicin—sarcoma	0.00471	0.00471	CcSEcCtD
Desonide—Infestation NOS—Doxorubicin—sarcoma	0.00466	0.00466	CcSEcCtD
Desonide—Infestation—Doxorubicin—sarcoma	0.00466	0.00466	CcSEcCtD
Desonide—Pharyngitis—Epirubicin—sarcoma	0.00448	0.00448	CcSEcCtD
Desonide—Sweating—Doxorubicin—sarcoma	0.00446	0.00446	CcSEcCtD
Desonide—Rash—Vincristine—sarcoma	0.00446	0.00446	CcSEcCtD
Desonide—Dermatitis—Vincristine—sarcoma	0.00445	0.00445	CcSEcCtD
Desonide—Oedema peripheral—Epirubicin—sarcoma	0.00445	0.00445	CcSEcCtD
Desonide—Headache—Vincristine—sarcoma	0.00443	0.00443	CcSEcCtD
Desonide—Rash—Mitoxantrone—sarcoma	0.00434	0.00434	CcSEcCtD
Desonide—Dermatitis—Mitoxantrone—sarcoma	0.00434	0.00434	CcSEcCtD
Desonide—Headache—Mitoxantrone—sarcoma	0.00431	0.00431	CcSEcCtD
Desonide—Pharyngitis—Doxorubicin—sarcoma	0.00415	0.00415	CcSEcCtD
Desonide—Oedema peripheral—Doxorubicin—sarcoma	0.00412	0.00412	CcSEcCtD
Desonide—Mediastinal disorder—Epirubicin—sarcoma	0.00407	0.00407	CcSEcCtD
Desonide—Pruritus—Etoposide—sarcoma	0.00405	0.00405	CcSEcCtD
Desonide—Mental disorder—Epirubicin—sarcoma	0.00396	0.00396	CcSEcCtD
Desonide—Erythema—Epirubicin—sarcoma	0.00393	0.00393	CcSEcCtD
Desonide—Mediastinal disorder—Doxorubicin—sarcoma	0.00377	0.00377	CcSEcCtD
Desonide—Mental disorder—Doxorubicin—sarcoma	0.00366	0.00366	CcSEcCtD
Desonide—Erythema—Doxorubicin—sarcoma	0.00364	0.00364	CcSEcCtD
Desonide—Rash—Etoposide—sarcoma	0.00361	0.00361	CcSEcCtD
Desonide—Dermatitis—Etoposide—sarcoma	0.00361	0.00361	CcSEcCtD
Desonide—Headache—Etoposide—sarcoma	0.00359	0.00359	CcSEcCtD
Desonide—Cough—Epirubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00333	0.00333	CcSEcCtD
Desonide—Infection—Epirubicin—sarcoma	0.00319	0.00319	CcSEcCtD
Desonide—Cough—Doxorubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Desonide—Nervous system disorder—Epirubicin—sarcoma	0.00315	0.00315	CcSEcCtD
Desonide—Skin disorder—Epirubicin—sarcoma	0.00312	0.00312	CcSEcCtD
Desonide—Hyperhidrosis—Epirubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Desonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00308	0.00308	CcSEcCtD
Desonide—Infection—Doxorubicin—sarcoma	0.00295	0.00295	CcSEcCtD
Desonide—Nervous system disorder—Doxorubicin—sarcoma	0.00291	0.00291	CcSEcCtD
Desonide—Skin disorder—Doxorubicin—sarcoma	0.00288	0.00288	CcSEcCtD
Desonide—Hyperhidrosis—Doxorubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Desonide—Pain—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Desonide—Pain—Doxorubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Desonide—Pruritus—Epirubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Desonide—Pruritus—Doxorubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Desonide—Rash—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Desonide—Dermatitis—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Desonide—Headache—Epirubicin—sarcoma	0.00201	0.00201	CcSEcCtD
Desonide—Rash—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Desonide—Dermatitis—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Desonide—Headache—Doxorubicin—sarcoma	0.00186	0.00186	CcSEcCtD
